Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Pharmacology   Volumes    Volume 18 
Hyperthermic intraperitoneal gemcitabine chemotherapy for patients with resected pancreatic cancer: Clinical and pharmacologic data
Paul H. Sugarbaker, O. Anthony Stuart, Lana Bijelic, Antonios-Apostolos K. Tentes
Pages: 81 - 92
Number of pages: 12
Current Topics in Pharmacology
Volume 18 

Copyright © 2014 Research Trends. All rights reserved

Worldwide, the surgical management of pancreas cancer using the Whipple procedure rarely results in long-term survival even though there is an R0 resection. This manuscript explores the use of hyperthermic intraperitoneal chemotherapy in the operating room to reduce local-regional progressive disease. Gemcitabine monotherapy administered in the operating room as hyperthermic intraperitoneal chemotherapy (HIPEC) is supported by pharmacologic data. The exposure as measured pharmacologically by the area under the curve (AUC) of intraperitoneal concentration times time, divided by plasma concentration times time is 200-500. Data suggests that improved local control with HIPEC with gemcitabine may facilitate an improvement in pancreas cancer treatment that leads the way to more successful strategies with systemic chemotherapy.
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms